D-Tails

D-Tails is an Italian private diagnostics and biotech company developing non-invasive tools for early detection of cancer and neurodegenerative disease. Its lead oncology effort is a urine-based screening approach that uses Caenorhabditis elegans olfactory responses and volatile organic compound signatures to detect early-stage cancers, with the company working toward a high-throughput screening kit. In neurodegeneration, D-Tails has developed BT1, a patented marker for detecting phosphorylated Tau protein in the retina for Alzheimer's research and early detection applications. The company also markets iFLUOR, an integrated wide-field fluorescence microscopy and microfluidics platform for live-cell and small-organism imaging. D-Tails operates as a translational R&D company linking academic research with scalable diagnostic instrumentation and research products.